SLN Competitors & Alternatives
Compare Silence Therapeutics PLC with similar stocks in the same industry
Biotechnology
SLN
Main Stock$6.95
Tradestie Score
55
Market Cap
$240.89M
Revenue Growth
2.0%
Analyst Upside
+349.2%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$13.77
|
$354.45M | - | 50 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$28.32
|
$353.70M | - | 56 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.65
|
$350.98M | - | 53 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.60
|
$341.56M | - | 55 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.53
|
$332.96M | - | 47 | Compare |
|
REPL
Replimune Group, Inc.
|
$8.89
|
$328.62M | - | 61 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.52
|
$304.12M | - | 58 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.87
|
$297.23M | - | 49 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.39
|
$293.03M | - | 60 | Compare |
|
OMER
Omeros Corporation
|
$9.36
|
$281.75M | 8.9 | 45 | Compare |
More SLN Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry